Transcatheter Therapeutics Conference In Brief

FDA combo products forum: Agency is expected to host a public meeting this fall to discuss its review of combination products, FDA Office of Drug Evaluation Cardio-Renal Products Division Director Doug Throckmorton reports. The collaboration between CDRH and the Center for Drug Evaluation and Research to review drug-eluting stents has been "a model" for future inter-center collaboration, Throckmorton reports at a Sept. 25 TCT FDA "town hall" meeting." In the meantime, the agency is seeking input from stakeholders on how the review of combination products can be improved and clarified...